Renovo Group plc

Company Information

Address:

Manchester Incubator Building
48 Grafton Street
Manchester
Greater Manchester
M13 9XX

Tel:

+44 (0) 161 276 7123

Fax:

+44 (0) 161 276 7240

E-Mail:

info@renovo.com

Secretary:

Davin Blain

Registrar:

Company Overview

Renovo is the world leader in scar prevention and reduction research, developing pharmaceutical products to prevent and reduce scarring in the skin, blood vessels, eyes, nerves, internal organs, tendons and ligaments. Our pipeline is extensive and includes four products in phase II clinical development, a further four advanced pre-clinical candidates and nine other pre-clinical candidates. There is an estimated multi-billion dollar global market for anti-scarring drugs, and Renovo aims to be first to market with a scar prevention pharmaceutical drug in the US and Europe to capitalise on this huge, unmet market need.

Annual Reports

Description Report Date Published
Annual Report 200930-09-200915-12-2009
Annual Report 200830-09-200811-12-2008
Annual Report 200730-09-200713-12-2007
Annual Report 200630-09-200614-12-2006

Interim Reports

Description Report Date Published
Interim Report 200931-03-200919-05-2009
Interim Report 200831-03-200829-05-2008
Interim Report 200731-03-200720-06-2007

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #